DNA Normality Following in Vitro Sperm Preparation with Pentoxifylline and L-Carnitine for Asthenozoospermic Infertile Men

Authors

  • Saad S. Al-Dujaily

  • Yahya K. Al-Sultani

  • Nawras N. Shams Alddin

Keywords:

pentoxifylline, l-carnitine, in vitro activation, layering preparation technique, male infertility

Abstract

Background: Sperm cells from infertile patients have poor motility and defected DNA. Pentoxifylline (PX) and L- carnitine (LC) are added in the medium for in vitro activation to increase sperm motility and improve the pregnancy outcome. However, there are few studies about the effect of PX with LC medium on sperm DNA normality. Objective: The goal of this study is to found out the optimum medium can increase the active motility percentage and reduce sperm DNA damage for asthenozoospermic men using the motility stimulant substances, PX and LC for this purpose. Methods: Semen was collected from 100 infertile men involved in the current study. Each semen sample was divided into four portions. One part was considered as a control group and in vitro activated by using culture medium only. The other portions were considered as treated groups and in vitro activated by adding PX (1mg) and/or LC (0.5mg) to the culture medium. Certain sperm function parameters were examined before and following in vitro activation using layering technique. Sperms DNA damage was detected by using acridine orange (AO) test. Results: The results revealed a highly significant (P

How to Cite

DNA Normality Following in Vitro Sperm Preparation with Pentoxifylline and L-Carnitine for Asthenozoospermic Infertile Men. (2013). Global Journal of Medical Research, 13(26), 25-30. https://medicalresearchjournal.org/index.php/GJMR/article/view/

Author Biography

Saad S. Al-Dujaily

Dr. Saad S. Al-Dujaily is a distinguished researcher and academic leader in the field of infertility and assisted reproductive technologies. He serves as Vice Dean for Scientific Affairs and Postgraduate Studies at the High Institute for Infertility Diagnosis and ART, Al-Nahrain University, Baghdad, Iraq. With 59 publications and 166 citations, his work focuses on sperm preparation techniques, including the use of progesterone, pentoxifylline, and herbal extracts for asthenozoospermic men. Dr. Al-Dujaily is also the General Secretary of the Iraqi Fertility Society. His research has contributed to understanding DNA normality and improving IUI outcomes. He is indexed in Scopus and OpenAlex, and holds an ORCID iD.

References

R. Abid (2005) Effect of pentoxifylline (Trental®) on human sperm in vitro activation of asthenospermic infertile patients.

E. Aliabadi, F. Karimi, M. Rasti, M. Akmali, T. Esmaeilpour (2013) Effects of l-carnitine and pentoxifylline on the activity of lactate dehydrogenase C4 isozyme and motility of testicular spermatozoa in mice. 14(2), 56-61.

H. Agarwal, K. Kulkarni (2003) Efficacy and safety of semen in patient with oligospermia: an open clinical study. Indian J. Clin. 14(2), 29-31.

A. Agarwal, Tamer Said (2004) Carnitines and male infertility. 8(4), 376-384. https://doi.org/10.1016/s1472-6483(10)60920-0

R. Aitken, J. Clarkson (1987) Cellular basis of defective sperm function and its association with the genesis of reactive oxygen species by human spermatozoa. 81(2), 459-469. https://doi.org/10.1530/jrf.0.0810459

S. Al-Dujaily, A. AL-Janabi, M. Nori (2006) Effect of Glycyrrhiza extract on in vitro sperm activation of asthenospermic patients. 11, 477-483.

S. Al-Dujaily, A. Al-Nakash, S. Al-Biaty (2007) Effect of pentoxifylline on the outcome of artificial inseminations. Iraqi post graduate. 5, 377-383.

S. Al-Dujaily, N. Al-Shahiri, A. Abbas (2012) Effect of L-carnitine on in vitro sperm activation of infertile men. 2(3), 22-25.

S. Al-Dujaily, K. Malik (2013) In vitro sperm activation for asthenospermic semen by using progesterone, pentoxifylline and Glycyrrhiza glabra extraction.Globel. 3(1), 1-6.

J. Alvarez (2003) Nuture vs nature: how can we optimize sperm quality?. 24, 640-648.

American Society for Reproductive Medicine (ASRM) (2010) Men's health. 1-5.

D. Aviad, H. Dettelbache (1984) Pharmacology of Pentoxifylline A Hemorheologic Agent for the Treatment of Intermittent Claudication. 35(7), 407-417. https://doi.org/10.1177/000331978403500703

Claudette, J. Lawrence, M. (1996) Role of free l-carnitine and acetyl-l-carnitine in post-gonadal maturation of mammalian spermatozoa. 2(2), 87-102.

M. Cocuzza, S. Sikka, K. Athayde (2007) Clinical relevance of oxidative stress and sperm chromatin damage in male infertility: an evidence based analysis. 33(5), 1-12.

E. De-Lamirande, C. Gagnon (1992) Reactive oxygen species and human spermatozoa. ll depletion of adenosine triphosphate plays an important role in the inhibition of sperm motility. J. 13, 379-386.

T. Diemer, M. Ludwig, P. Huwe, Hales D.B (2000) Influence of urogenital infection on sperm function. Curr. Opin. 10(1), 39-44. https://doi.org/10.1097/00042307-200001000-00010

G. Dohle, A. Jungwirth, G. Colpi, T. Diemer (2007) Guide line on male infertility. 11, 8-21.

E. Gil-Guzman, M. Ollero, M. Lopez (2001) Differential production of reactive oxygen species by subsets of human spermatozoa at different stages of maturation. 16.

J. Hall, S. Fishel, S. Green, S. Fleming, A. Hunter, N. Stoddert, K. Dowell, S. Thornton (1995) Intracytoplasmic sperm injection versus high insemination concentration in-vitro fertilization in cases of very severe teratozoospermia. 10, 493-496.

Ralf Henkel, Wolf-Bernhard Schill (2003) Sperm preparation for ART. 1(1), 99-115. https://doi.org/10.1186/1477-7827-1-108

Nechama Kosower, Haruo Katayose, Ryuzo Yanagimachi (1992) Thiol‐Disulfide Status and Acridine Orange Fluorescence of Mammalian Sperm Nuclei. 13(4), 342-348. https://doi.org/10.1002/j.1939-4640.1992.tb00335.x

F. Lambardo, L. Gandini, A. Lenzi, F. Dondero (2004) Antisperm immunity in assisted reproduction. 62(1-2), 101-109. https://doi.org/10.1016/j.jri.2003.08.005

K. McKinney, S. Lewis, W. Thompson (1996) The effects of pentoxifylline on the generation of reactive oxygen species and lipid peroxidation in human spermatozoa. 28(1), 15-20. https://doi.org/10.1111/j.1439-0272.1996.tb02752.x

Y. Menezo, A. Hazout, G. Panteix, F. Robert, J. Rollet, P. Cohen-Bacrie (2007) Antioxidants to reduce sperm DNA fragmentation: an unexpected adverse effect. 14(4), 418-421. https://doi.org/10.1016/s1472-6483(10)60887-5

D. Muller, H. Seim, W. Kiess, H. Loster, T. Richter (2002) Effects of oral l-carnitine supplementation on in vivo long-chain fatty acid oxidation in healthy adults. Univ. Leipzig, Children's Hospital, Germany. 51(11), 1389-1391.

H. Okada, N. Tatsumi, M. Kanzaki (1997) Formation of Reactive Oxygen Species by Spermatozoa From Asthenospermic Patients: Response to Treatment With Pentoxifylline. 157(6), 2140-2146. https://doi.org/10.1016/s0022-5347(01)64697-4

G. Oosterhuis, Andre Mulder, Ellen Kalsbeek-Batenburg, Cornelis Lambalk, Joop Schoemaker, Istvan Vermes (2000) Measuring apoptosis in human spermatozoa: a biological assay for semen quality?. 74(2), 245-250. https://doi.org/10.1016/s0015-0282(00)00623-3

M. Sato, A. Ishikawa (2004) Room temperature storage of mouse epididymal spermatozoa: exploration of factors affecting sperm survival. 61(7-8), 1455-1469.

Ryan Schulte, Dana Ohl, Mark Sigman, Gary Smith (2010) Sperm DNA damage in male infertility: etiologies, assays, and outcomes. J. Assist. Reprod. 27(1), 3-12. https://doi.org/10.1007/s10815-009-9359-x

R. Sharma, T. Said, A. Agarwal (2004) Sperm DNA damage and its clinical relevance in assessing reproductive outcome. Asian. J. 6, 139-148.

Suresh Sikka (2001) Relative impact of oxidative stress on male reproductive function. Curr. Med. 8(7), 851-862. https://doi.org/10.2174/0929867013373039

E. Sills, Julie Fryman, M. Perloe, Karin Michels, M. Tucker (2004) Chromatin fluorescence characteristics and standard semen analysis parameters correlations observed in andrology testing among 136 males referred for infertility evaluation. J. Obstet. 24(1), 74-77. https://doi.org/10.1080/01443610310001620369

K. Solarska, A. Lewinska, A. Karowicz-Bilinska, G. Bartosz (2010) The antioxidant properties of carnitine in vitro. Cell. Mol. Biol. 15(1), 90-97. https://doi.org/10.2478/s11658-009-0036-y

D. Sorlie (1995) Examination and Board Review: Medical Biostatistics and Epidemiology. (1st ed.). 47-88.

P. Stanic, Z. Sonicki, E. Suchanek (2002) Effect of pentoxifylline on motility and membrane integrity of cryopreserved human spermatozoa. 25(3), 186-190. https://doi.org/10.1046/j.1365-2605.2002.00348.x

A. Steiber, J. Kerner, C. Hoppelm (2004) Carnitine: a nutritional, biosynthetic, and functional perspective. 25(5-6), 455-473.

Rafael Tejada, J. Mitchell, Amos Norman, Jaroslav Marik, Stanley Friedman (1984) A test for the practical evaluation of male fertility by acridine orange (AO) fluorescence. 42(1), 87-91. https://doi.org/10.1016/s0015-0282(16)47963-x

J. Twigg, D. Irvine, P. Houston, N. Fulton, L. Michael, R. Aitken (1998) Iatrogenic DNA damage induced in human spermatozoa during sperm preparation: protective significance of seminal plasma. 4(5), 439-445. https://doi.org/10.1093/molehr/4.5.439

World Health Organization (WHO) (1999) World Health Organization Laboratory Manual for the Examination of Human Semen and Sperm‐Cervical Mucus Interaction, 4th ed. 4-59.

World Health Organization WHO (2010) Laboratory Manual for Examination and Processing of Human Semen.

DNA Normality Following In Vitro Sperm Preparation with Pentoxifylline and L-Carnitine for  Asthenozoospermic Infertile Men

Published

2013-10-02

How to Cite

DNA Normality Following in Vitro Sperm Preparation with Pentoxifylline and L-Carnitine for Asthenozoospermic Infertile Men. (2013). Global Journal of Medical Research, 13(26), 25-30. https://medicalresearchjournal.org/index.php/GJMR/article/view/